home / stock / ophly / ophly news


OPHLY News and Press, Ono Pharmaceutical Co Ltd ADR

Stock Information

Company Name: Ono Pharmaceutical Co Ltd ADR
Stock Symbol: OPHLY
Market: OTC

Menu

OPHLY OPHLY Quote OPHLY Short OPHLY News OPHLY Articles OPHLY Message Board
Get OPHLY Alerts

News, Short Squeeze, Breakout and More Instantly...

OPHLY - Pfizer wins full FDA approval for Braftovi in colorectal cancer

2026-02-24 13:26:25 ET More on Pfizer, Ono Pharmaceutical Pfizer: A Risky 6.3% Yield For Income-Oriented Investors Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades) Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts ...

OPHLY - Pfizer says cancer therapy Braftovi improved survival in late-stage trial

2026-02-17 09:11:22 ET More on Pfizer Pfizer: A Great Opportunity Post Earnings Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity Pfizer Inc. 2025 Q4 - Results - Earnings Call Presentation Changes to U.S. vaccine poli...

OPHLY - Ono Pharmaceutical GAAP EPS of ¥146.07, revenue of ¥397.04B; reaffirms FY outlook

2026-02-02 01:11:53 ET More on Ono Pharmaceutical Co., Ltd. Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ...

OPHLY - Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-14 18:16:01 ET Ono Pharmaceutical Co., Ltd. (OPHLY) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 2:15 PM EST... Read the full article on Seeking Alpha For further details see: Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan ...

OPHLY - Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 FY2025 Earnings Call Transcript

2025-08-03 21:36:32 ET Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 FY2025 Earnings Conference Call August 01, 2025 01:00 AM ET Company Participants Hirokazu Kitada - Corporate Participant Sales and Marketing - Corporate Participant Hiroyuki Takahashi - Director of On...

OPHLY - Vertex and Ono Pharmaceutical form exclusive alliance for Povetacicept in Japan and South Korea

2025-06-23 04:50:15 ET Vertex Pharmaceuticals ( Nasdaq: NASDAQ: VRTX ) and Ono Pharmaceutical ( OTCMKTS: OTCPK:OPHLY ) have announced an exclusive collaboration, for the development and commercialization of Vertex's povetacicept in Japan and South Korea.... Re...

OPHLY - Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

- Exclusive collaboration and license agreement for povetacicept in these countries - - Ono will leverage its deep expertise in clinical development and commercialization for chronic kidney disease in Japan and South Korea to accelerate advancement of povetacicept for patients with IgA ne...

OPHLY - Top 5 Penny Stocks - Healthcare

2025-04-08 20:08:16 ET Below are the top 5 penny stocks screened from our system based on their highest market capitalization, traded volume and 1-Day Change% in Healthcare sector. WuXi Biologics (Cayman) Inc. (WXXWY) WXXWY is trading DOWN for the last 6 days, and it at trading at...

OPHLY - Ionis out licenses blood disorder therapy to Ono in a deal worth up to $940M

2025-03-12 06:53:54 ET More on Ionis Pharmaceuticals, Ono Pharmaceutical, etc. Ionis Pharmaceuticals, Inc. (IONS) Q4 2024 Earnings Call Transcript Ionis Pharmaceuticals Reports Strong Q4 Earnings After Recent FDA Approval Ionis Pharmaceuticals, Inc. 2024 Q4 - Results...

OPHLY - Ono Pharmaceutical GAAP EPS of ¥162.87, revenue of ¥374.56B; reaffirms FY outlolok

2025-02-03 04:16:43 ET More on Ono Pharmaceutical Historical earnings data for Ono Pharmaceutical Dividend scorecard for Ono Pharmaceutical Financial information for Ono Pharmaceutical Read the full article on Seeking Alpha For further details see: ...

Next 10